NCT01946555View on ClinicalTrials.gov

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
TumorCancer PainBreakthrough Cancer PainNeuropathic Pain
Interventions
DRUG

Morphine

DRUG

Fentanyl

DRUG

Methadone

DRUG

Buprenorphine

DRUG

Oxycodone

DRUG

Hydromorphone

DRUG

Tapentadol

Trial Locations (11)

41124

AO Universitaria Policlinico di Modena, Modena

Unknown

A.O. Universitaria Parma, Parma

Ospedale Magati, Scandiano

Azienda USL - Ospedale di Carpi e Mirandola, Carpi

A.O.U. Arcispedale S. Anna, Ferrara

Ospedale di Fiorenzuola D'Arda, Fiorenzuola d'Arda

Ospedale di Lugo, Lugo

IRCCS-IRST Forlì, Meldola

Ospedale di Piacenza, Piacenza

Arcispedale S. Maria Nuova Azienda Ospedaliera, Reggio Emilia

Ospedale degli Infermi, Rimini

All Listed Sponsors
lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT01946555 - Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain | Biotech Hunter | Biotech Hunter